Neuroscientific Biopharmaceuticals (ASX:NSB)

ASX announcement history & article coverage

12
Total announcements
(in last 3 months)
1
With article
11
No article
Article coverage
8%
Transparent by design. Announcments by Neuroscientific Biopharmaceuticals (ASX:NSB) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

1 July 2026 · 09:56 am AEST ASX Filing
Notification of cessation of securities - NSB

19 June 2026 · 01:12 pm AEST ASX Filing
Escrowed Securities Update
11 June 2026 · 12:50 pm AEST ASX Filing
Investor Webinar
9 June 2026 · 08:21 am AEST ASX Filing
Change in substantial holding
3 June 2026 · 05:26 pm AEST ASX Filing
Becoming a substantial holder
2 June 2026 · 05:41 pm AEST ASX Filing
Change of Director's Interest Notice x2
1 June 2026 · 05:35 pm AEST ASX Filing
Section 708A Notice
1 June 2026 · 05:30 pm AEST ASX Filing
Application for quotation of securities - NSB

26 May 2026 · 12:17 pm AEST ASX Filing
Updated Presentation - Successful Results
26 May 2026 · 09:30 am AEST ⚡ Price Sensitive ASX Filing
Remarkable Results from Patients treated with StemSmart
25 May 2026 · 09:44 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt

30 Apr 2026 · 08:46 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
NeuroScientific reports positive StemSmart clinical results, advances manufacturing and Phase 2 trial plans